Inventor
YONG-LIANG ZHU
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07DHeterocyclic compounds21%
C07CAcyclic or carbocyclic compounds13%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms13%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
PatentTitleYear
12,403,145Substituted quinazolines for inhibiting kinase activity202512,018,002Certain chemical entities, compositions, and methods202411,865,120Substituted quinazolines for inhibiting kinase activity202411,304,957Substituted quinazolines for inhibiting kinase activity202211,208,388Certain chemical entities, compositions, and methods2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to NEUPHARMA INC (5)· patent assignee history
2021–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NEUPHARMA INC | 5 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2021–2025 |